DXLG — Destination XL Group, Inc.

Summary of DXLG Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 Sales: $112.1 million, down from $119.2 million in Q4 2024.
• Comparable Sales: Decreased 7.3% in Q4; stores down 8.6%, direct business down 4.3%.
• Full-Year Sales: $435.0 million, down from $467.0 million in 2024.
• Full-Year Comparable Sales: Decreased 8.4%; stores down 6.9%, direct down 11.8%.
• Gross Margin: 40.8% in Q4, down from 44.4% in Q4 2024; full-year gross margin at 43.4%, down from 46.5%.
• Adjusted EBITDA: $1.6 million for the full year, significantly down from $19.9 million in the previous year.
• Cash Position: Ended the year with $28.8 million in cash and no debt.

2. Strategic Updates and Business Highlights

• Merger with FullBeauty Brands: Ongoing preparations for the merger, with a proxy statement expected within 30 days. The transaction is anticipated to close in 2026, pending shareholder approval.
• FitMap Technology: Expanded rollout to 188 stores, with a focus on increasing customer scanning and engagement. The technology aims to improve fit and reduce returns.
• Private Brand Strategy: Plans to increase private brand offerings from 57% to 65% by 2027, which is expected to enhance gross margins due to higher initial markup (IMU).
• Store Openings: Eight new stores opened in 2025, with a pause on further openings due to economic headwinds. Future focus on converting existing Casual Male stores and maintaining current locations.

3. Forward Guidance and Outlook

• Sales Expectations: Optimistic about improving sales momentum in 2026, aiming for breakeven in comparable sales by summer and positive growth later in the year.
• Capital Expenditures: Expected to range from $8 million to $12 million in 2026, primarily for technology and infrastructure projects.
• No Specific Financial Guidance: Further financial guidance will be provided post-merger completion.

4. Bad News, Challenges, or Points of Concern

• Declining Sales: Significant decline in comparable sales for both Q4 and the full year, reflecting ongoing challenges in the big and tall retail sector.
• Gross Margin Pressure: Decreased gross margins due to lower merchandise margins and occupancy costs, compounded by tariffs and promotional markdowns.
• Impact of GLP-1 Drugs: Noted volatility in customer behavior linked to weight loss medications, affecting purchasing patterns and size transitions.
• Weather-Related Disruptions: Severe weather events in January negatively impacted sales, with a notable drop in store traffic.

5. Notable Q&A Insights

• FitMap Technology: Management highlighted the importance of training staff to maximize the benefits of FitMap, with expectations of double-digit revenue increases from scanned customers.
• Promotional Environment: Competitive pressures noted in the big and tall market, with a shift in consumer preference towards private brands due to perceived value.
• Store Fleet Strategy: Management indicated a cautious approach to store openings, focusing on existing locations and customer feedback regarding store accessibility.
• GLP-1 Drug Impact: Management acknowledged the evolving impact of GLP-1 drugs on customer purchasing behavior, with a significant portion of customers reportedly using these medications and delaying clothing purchases.

Overall, while Destination XL Group, Inc. faces significant challenges with declining sales and margin pressures, there are strategic initiatives in place aimed at improving customer engagement and financial performance moving into 2026.